Brinker Capital Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Sell |
33,513
-1,977
| -6% | -$174K | 0.03% | 597 |
|
|
2025
Q1 | $3.23M | Buy |
35,490
+5,610
| +19% | +$511K | 0.03% | 496 |
|
|
2024
Q4 | $2.58M | Sell |
29,880
-985
| -3% | -$85K | 0.03% | 575 |
|
|
2024
Q3 | $2.93M | Sell |
30,865
-991
| -3% | -$94.2K | 0.03% | 517 |
|
|
2024
Q2 | $2.91M | Sell |
31,856
-1,111
| -3% | -$102K | 0.03% | 488 |
|
|
2024
Q1 | $2.99M | Sell |
32,967
-1,844
| -5% | -$167K | 0.03% | 478 |
|
|
2023
Q4 | $2.96M | Sell |
34,811
-3,227
| -8% | -$274K | 0.03% | 450 |
|
|
2023
Q3 | $3.04M | Sell |
38,038
-2,290
| -6% | -$183K | 0.04% | 437 |
|
|
2023
Q2 | $3.18M | Sell |
40,328
-1,292
| -3% | -$102K | 0.03% | 462 |
|
|
2023
Q1 | $3.23M | Buy |
+41,620
| New | +$3.23M | 0.04% | 400 |
|
|
2021
Q2 | – | Sell |
-70,000
| Closed | -$4.83M | – | 1347 |
|
|
2021
Q1 | $4.83M | Sell |
70,000
-40,000
| -36% | -$2.76M | 0.07% | 273 |
|
|
2020
Q4 | $7.31M | Sell |
110,000
-32,151
| -23% | -$2.14M | 0.11% | 213 |
|
|
2020
Q3 | $8.84M | Sell |
142,151
-80,000
| -36% | -$4.97M | 0.15% | 163 |
|
|
2020
Q2 | $13.8M | Sell |
222,151
-7,000
| -3% | -$436K | 0.58% | 49 |
|
|
2020
Q1 | $12.5M | Buy |
229,151
+151
| +0.1% | +$8.21K | 0.57% | 53 |
|
|
2019
Q4 | $14.7M | Hold |
229,000
| – | – | 0.49% | 56 |
|
|
2019
Q3 | $13.1M | Sell |
229,000
-14,000
| -6% | -$798K | 0.45% | 59 |
|
|
2019
Q2 | $14.3M | Sell |
243,000
-4,000
| -2% | -$235K | 0.45% | 64 |
|
|
2019
Q1 | $15M | Buy |
247,000
+100,000
| +68% | +$6.07M | 0.48% | 58 |
|
|
2018
Q4 | $8.05M | Buy |
+147,000
| New | +$8.05M | 0.28% | 89 |
|
|
2018
Q3 | – | Sell |
-147,000
| Closed | -$8.67M | – | 687 |
|
|
2018
Q2 | $8.67M | Hold |
147,000
| – | – | 0.28% | 84 |
|
|
2018
Q1 | $8.35M | Buy |
147,000
+3,000
| +2% | +$170K | 0.27% | 86 |
|
|
2017
Q4 | $8.54M | Buy |
144,000
+122,000
| +555% | +$7.24M | 0.28% | 80 |
|
|
2017
Q3 | $1.27M | Buy |
+22,000
| New | +$1.27M | 0.05% | 190 |
|